Home – Ranitidine Hydrochloride
Ranitidine Hydrochloride
REMEDYREPACK INC.
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
RANITIDINE HYDROCHLORIDE DESCRIPTION
CLINICAL PHARMACOLOGY
PHARMACOKINETICS
PHARMACODYNAMICS
PHARMACODYNAMICS
INDICATIONS & USAGE
RANITIDINE HYDROCHLORIDE CONTRAINDICATIONS
PRECAUTIONS
LABORATORY TESTS
LABORATORY TESTS
DRUG INTERACTIONS
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
PREGNANCY
NURSING MOTHERS
PEDIATRIC USE
PEDIATRIC USE
GERIATRIC USE
GERIATRIC USE
RANITIDINE HYDROCHLORIDE ADVERSE REACTIONS
ADVERSE REACTIONS
OVERDOSAGE
OVERDOSAGE
DOSAGE & ADMINISTRATION
DOSAGE & ADMINISTRATION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
Ranitidine Hydrochloride
Ranitidine Hydrochloride TABLET
Product Information
|
Product Type
|
Human prescription drug label |
Item Code (Source)
|
NDC:49349-165(NDC:60505-0025-8) |
Route of Administration
|
ORAL |
DEA Schedule
|
|
Product Characteristics
|
Color
|
Size
|
Imprint Code
|
Shape
|
white |
8 mm |
RAN;150;APO |
ROUND |
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:49349-165-02 |
30 in 1 BLISTER PACK |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
ANDA |
ANDA074680 |
2011-04-14 |
|
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!